Popular Articles

Texas "Medical Home" Provides Personal And Coordinated Health Care
The Houston Chronicle reports on a medical philosophy that focuses on providing coordinated care and personal care to older patients, mostly indigent seniors. The paper examines Select Senior Clinic, a Texas facility that ascribes to the medical home concept.
diet pills
JHPIEGO's Dr. Harshad Sanghvi Receives International Health Award - Global Health Council Present Award For Best Practices In Global Health On May 28
Jhpiego, an international non-profit health organization affiliated with Johns Hopkins University, is pleased to announce that Dr. Harshad Sanghvi, Vice President and Medical Director of Jhpiego, has been awarded the 2009 Award for Best Practices in Global Health from the Global Health Council.
News of the day
The Development Of Mechanosensitivity
Researchers of the Max DelbrÃøck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have gained crucial insight into how mechanosensitivity arises. By measuring electrical impulses in the sensory neurons of mice, the neurobiologists and pain researchers Dr. Stefan G. Lechner and Professor Gary Lewin were able to directly elucidate, for the first time, the emergence of mechanosensitivity. At the same time they were able to show that neurons develop their sensitivity to touch and pain during different developmental phases but always coincidentally with the growth of the neuronal pathways. (EMBO Journal, 2009, doi:10.1038/emboj.2009.73).*
Endocrinology

Genome Sequencing Of Schistosomiasis Parasites Could Promote Drug Development

Researchers have sequenced the genomes of two parasites that cause bilharzia or schistosomiasis - a disease transmitted by water-borne snails that affects more than 200 million people worldwide - "revealing potential weaknesses that could be exploited by drug developers," Nature reports (Smith, 7/15). The study, which was published on Wednesday in the journal Nature, was conducted by two international teams of scientists that identified the genetic chemical sequences of two of the five harmful species of the parasite, S. mansoni and S. japonicum, Press Association/Google.com reports (7/15). Researchers found that S. masoni, "the most widespread of the schistomiasis parasites," is comprised of almost 12,000 genes - "about 10 times the size of the malaria parasite genome," according to the BBC. The analysis also found that S. mansoni does not have "a key enzyme needed to make essential fats, and must rely on its host to provide these - revealing a potential Achilles" heel" that could be used to create new drugs, the BBC writes (7/16). The study "explores cost effective ways to develop new therapies, such as the possibility that existing pharmaceutical drugs might be used to target schistosomiasis," according to a University of Maryland press release (7/15). The drug praziquantel, which is "cheap" and "effective," is currently used to treat the disease, but the concern has been that it "does not prevent people from getting re-infected by bathing in infested waters, and reinfection offers plenty of opportunities for the parasite to become resistant," according to AFP/Yahoo! News. Anthony Fauci - director of U.S. National Institute of Allergy and Infectious Diseases, which funded a portion of the research - said, "Chronic infection with schistosoma parasites makes life miserable for millions of people in tropical countries around the globe." He added, "New drugs and other interventions are badly needed" (7/15). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):